Chemeq raises $25m
25 June, 2003 by Melissa TrudingerPerth biotechnology company Chemeq (ASX: CMQ) has raised a whopping $AUD25 million in a share placement to institutional and sophisticated investors.
Consuming passions
25 June, 2003 by Jeremy TorrThe consumables market in Australia has long been supported by the lab, mining and agricultural customer. But now, biotech is changing the landscape. Faster moving, smaller and more disposable, consumables are making the move to a technology based market. Jeremy Torr reports
NSCC collaborates with LifeCell
23 June, 2003 by Melissa TrudingerThe National Stem Cell Centre (NSCC) has recruited expatriate Australian scientist Dr Stephen Livesey to be the chief scientific officer of the Centre, Victorian Premier Steve Bracks has announced on the eve of the BIO2003 conference in Washington DC.
Queensland BioCapital Fund announces first investment
19 June, 2003 by Pete YoungQueensland Premier Peter Beattie has opened his campaign to grab a slice of the spotlight for the State during Bio2003 by announcing the first investment by Australia’s largest biotechnology fund, the $100 million Queensland BioCapital Fund.
NSW pledges $205 million for new Institute
19 June, 2003 by Jeremy TorrThe NSW government has taken the first step towards fulfilling its election pledge, with $205million on the table over the next four years as funding for the new peak cancer research organsation.
Oz biotechs beat the bulls
17 June, 2003 by Jeremy TorrLocal biotech performers have overtaken the traditional basket of stocks by 13 per cent, showing a 27 per cent leap in prices, according to a report from stockbroking firm Intersuisse.
Research teams receive $73m in latest NHMRC grants
16 June, 2003 by Melissa TrudingerMore than $AUD73 million has been awarded to 11 research teams based in Victoria, New South Wales and Queensland in the latest round of the NHMRC's program grants.
Australian Biotech Alliance formed
13 June, 2003 by Melissa TrudingerThe competition between Victoria, NSW and Queensland over which state has the best biotechnology industry appears to have been resolved today with an agreement to form the Australian Biotech Alliance.
Majority shareholder joins Biota board
12 June, 2003 by Melissa TrudingerFarooq Khan must be quietly seething. Biota has just appointed a director, Andrew Tyndale, from the ranks of new majority shareholder Babcock & Brown.
Crystallographers receive a boost
12 June, 2003 by Melissa TrudingerMelbourne's protein crystallographers have received a boost with the recent acquisition of a $AUD720,000 X-ray Crystallography generator system at the Austin Research Institute (ARI).
How M&A could raise biotech's living dead
11 June, 2003 by Pete YoungSome Australian listed biotechs are trapped in a death spiral. Shareholders are reluctant to top up their original investments, while cash burn rates tip them ever closer to the edge of insolvency. But there are bright spots, writes Pete Young
Cause for cheer, cause for gloom
10 June, 2003 by Jeremy TorrTwo dedicated market watchers have decreed that it is time for an upturn in the biotech sector, not just in the US but in Australia too. But local fund managers may not yet have the ticker to make it happen.
Monash boosts commerce
10 June, 2003 by Jeremy Torr“Monash is making a major commitment to the commercialisation process. We have gone out on a limb in many ways, in doing what we have done.”
Novogen flexes patent muscles
10 June, 2003 by Jeremy TorrNovogen’s US-based licensee The Solae Company has filed patent infringement suits against two of America’s biggest dietary and health supplement makers.
Xcell's hair analysis gets German nod
06 June, 2003 by Jeremy TorrXcell has received European regulatory approval for its video-dermatoscope hair analysis expert system, designed to replace the traditional and painful trichographic method.
